3.8 Article

Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious infiltrative disease caused by the deposition of amyloid fibrils in the heart, which can be due to genetic variants or acquired conditions. With advances in imaging techniques, non-invasive diagnosis is now possible, showing that cardiac amyloidosis is more common than previously thought. The Working Group on Myocardial and Pericardial Disease has proposed definitions and diagnostic algorithms for cardiac amyloidosis.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy

Shingo Ota et al.

Summary: This study indicates that patients with multiple LGE lesions in non-ischemic cardiomyopathy have a higher risk of cardiac events and poorer left ventricular reverse remodeling. The LGE pattern may be useful for improved risk stratification in patients with NICM.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by amyloid fibril deposition in the heart. Advances in imaging techniques and diagnostic algorithms have made it possible to diagnose the condition non-invasively. Monitoring and treating cardiac amyloidosis are important in bridging the gap between research advances and clinical practice.

EUROPEAN HEART JOURNAL (2021)

Review Cardiac & Cardiovascular Systems

How to Image Cardiac Amyloidosis A Practical Approach

Sharmila Dorbala et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Cardiac & Cardiovascular Systems

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

Michelle M. Kittleson et al.

CIRCULATION (2020)

Review Hematology

Management of AL amyloidosis in 2020

Giovanni Palladini et al.

BLOOD (2020)

Article Cardiac & Cardiovascular Systems

Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging

Wouter P. te Rijdt et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2019)

Article Medicine, General & Internal

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biochemistry & Molecular Biology

First nationwide survey on systemic wild-type ATTR amyloidosis in Japan

Yoshiki Sekijima et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)

Article Cardiac & Cardiovascular Systems

Predictors of survival stratification in patients with wild-type cardiac amyloidosis

F. Aus Dem Siepen et al.

CLINICAL RESEARCH IN CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disprovingmyths

Esther Gonzalez-Lopez et al.

EUROPEAN HEART JOURNAL (2017)

Article Cardiac & Cardiovascular Systems

Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy

Tetsuo Konno et al.

AMERICAN JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore et al.

CIRCULATION (2016)

Article Cardiac & Cardiovascular Systems

Prognostic implication of relative regional strain ratio in cardiac amyloidosis

Alpana Senapati et al.

HEART (2016)

Article Cardiac & Cardiovascular Systems

Cardiac amyloidosis: the great pretender

Claudio Rapezzi et al.

HEART FAILURE REVIEWS (2015)

Article Cardiac & Cardiovascular Systems

Prevalence and Prognostic Significance of Low QRS Voltage Among the Three Main Types of Cardiac Amyloidosis

Nicole B. Cyrille et al.

AMERICAN JOURNAL OF CARDIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Left Ventricular Structure and Function in Transthyretin- Related Versus Light- Chain Cardiac Amyloidosis

Candida Cristina Quarta et al.

CIRCULATION (2014)

Review Cardiac & Cardiovascular Systems

LVH and the diagnosis of STEMI - how should we apply the current guidelines?

Yochai Birnbaum et al.

JOURNAL OF ELECTROCARDIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

Jennifer H. Pinney et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)

Article Cardiac & Cardiovascular Systems

Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types

Claudio Rapezzi et al.

CIRCULATION (2009)

Article Cardiac & Cardiovascular Systems

Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram

Christopher J. McLeod et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

An improved MR imaging technique for the visualization of myocardial infarction

OP Simonetti et al.

RADIOLOGY (2001)